Description

Peramivir is a potent neuraminidase inhibitor antiviral drug, specifically designed to combat influenza viruses. Its primary value lies in its ability to effectively treat and manage influenza A and B infections, offering a critical therapeutic option in global healthcare. This compound is essential for pharmaceutical manufacturers, research institutions, and contract development organizations involved in producing antiviral medications, conducting virology research, and developing new therapeutic formulations.

Application

• Active Pharmaceutical Ingredient (API): Core component in the manufacture of injectable antiviral drugs for the treatment of influenza.
• Pharmaceutical Research & Development: Used as a reference standard and key intermediate in the discovery and development of next-generation neuraminidase inhibitors.
• Virology Studies: Employed in in vitro and in vivo studies to understand influenza virus replication and evaluate antiviral efficacy.
• Contract Manufacturing: Supplied to CDMOs for the production of finished dosage forms under cGMP guidelines.
• Combinatorial Therapy Development: Investigated for use in combination therapies to enhance treatment outcomes and combat drug-resistant influenza strains.

Basic Information

Product Name	Peramivir
CAS No.	383910-22-3
Molecular Formula	C15H28N4O4
Molecular Weight	328.41 g/mol
Synonyms	Peramivir Anhydrous; (1S,2S,3R,4R)-3-[(1S)-1-Acetamido-2-ethylbutyl]-4-(diaminomethylideneamino)-2-hydroxycyclopentane-1-carboxylic acid; BCX-1812; RWJ-270201; Rapiacta; Alpivab; Peramivirum
EINECS	Contact for details

Quality Control

Our Peramivir is manufactured and tested to meet stringent pharmaceutical-grade standards. Quality is assured through a comprehensive analytical program including HPLC, NMR, and mass spectrometry for identity and purity confirmation. We adhere to cGMP principles, and a detailed Certificate of Analysis (COA) is provided with each batch, documenting compliance with established specifications for assay, impurities, residual solvents, and microbiological quality.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept in a dry environment to maintain stability and potency.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference standard
Identification (HPLC)	Conforms to reference standard
Assay (HPLC)	98.0% - 102.0% (on anhydrous basis)
Water Content (KF)	≤ 1.0%
Residual Solvents (GC)	Meets ICH Q3C guidelines
Related Substances (HPLC)	Individual unknown impurity: ≤ 0.10% Total impurities: ≤ 1.0%
Heavy Metals	≤ 20 ppm
Microbiological Enumeration	Meets Ph. Eur. 2.6.12/ USP <61> requirements

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.